Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Dall

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
The Canadian Journal of Urology|December 16, 2020
A case of acute vasitis mimicking an incarcerated inguinal hernia with subtle imaging findingsChristopher Dall, Kenneth Lim, George Khludenev, et al.
Life Sciences|April 20, 2016
Oxygen cycling to improve survival of stem cells for myocardial repair: A reviewChristopher Dall, Mahmood Khan, Chun-An Chen, et al.
Current Oncology (Toronto, Ont.)|December 22, 2022
Salvage Retzius-Sparing Radical Prostatectomy: A Review of Complications, Functional Outcomes, and Oncologic OutcomesJ Bradley Mason, Liam Hatch, Christopher Dall, et al.
JAMA Surgery|October 15, 2025
Surgery at High-Quality Hospitals Among Medicare Advantage Beneficiaries Undergoing Cancer SurgeryAvinash Maganty, Xiu Liu, Christopher Dall, et al.
Urology Practice|August 28, 2024
The 340B Program and High-Risk Prescribing of Oral Targeted Therapies for Advanced Prostate CancerKassem S Faraj, Mary Oerline, Samuel R Kaufman, et al.
Cancer Medicine|December 31, 2024
The 340B Drug Pricing Program and Management of Advanced Prostate CancerKassem S Faraj, Samuel R Kaufman, Mary Oerline, et al.
The Canadian Journal of Urology|June 12, 2022
Prognostic factors for overall survival in malignant ureteral obstructionJ Bradley Mason, Michael Creswell, Jillian Egan, et al.
Journal of the National Cancer Institute|July 25, 2024
Adverse events in men with advanced prostate cancer treated with androgen biosynthesis inhibitors and androgen receptor inhibitorsKassem S Faraj, Mary Oerline, Samuel R Kaufman, et al.
Cancer Medicine|January 11, 2026
Impact of In-Office Dispensing Adoption by Urology Practices on Oral Specialty Drug Use in Advanced Prostate CancerKassem S Faraj, Mary Oerline, Samuel R Kaufman, et al.
Cancer|November 6, 2024
Commercial prices and their influence on urology practices: Prostate cancer care among men with MedicareArnav Srivastava, Xiu Liu, Avinash Maganty, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
The Canadian Journal of Urology|December 16, 2020
A case of acute vasitis mimicking an incarcerated inguinal hernia with subtle imaging findingsChristopher Dall, Kenneth Lim, George Khludenev, et al.
Life Sciences|April 20, 2016
Oxygen cycling to improve survival of stem cells for myocardial repair: A reviewChristopher Dall, Mahmood Khan, Chun-An Chen, et al.
Current Oncology (Toronto, Ont.)|December 22, 2022
Salvage Retzius-Sparing Radical Prostatectomy: A Review of Complications, Functional Outcomes, and Oncologic OutcomesJ Bradley Mason, Liam Hatch, Christopher Dall, et al.
JAMA Surgery|October 15, 2025
Surgery at High-Quality Hospitals Among Medicare Advantage Beneficiaries Undergoing Cancer SurgeryAvinash Maganty, Xiu Liu, Christopher Dall, et al.
Urology Practice|August 28, 2024
The 340B Program and High-Risk Prescribing of Oral Targeted Therapies for Advanced Prostate CancerKassem S Faraj, Mary Oerline, Samuel R Kaufman, et al.
Cancer Medicine|December 31, 2024
The 340B Drug Pricing Program and Management of Advanced Prostate CancerKassem S Faraj, Samuel R Kaufman, Mary Oerline, et al.
The Canadian Journal of Urology|June 12, 2022
Prognostic factors for overall survival in malignant ureteral obstructionJ Bradley Mason, Michael Creswell, Jillian Egan, et al.
Journal of the National Cancer Institute|July 25, 2024
Adverse events in men with advanced prostate cancer treated with androgen biosynthesis inhibitors and androgen receptor inhibitorsKassem S Faraj, Mary Oerline, Samuel R Kaufman, et al.
Cancer Medicine|January 11, 2026
Impact of In-Office Dispensing Adoption by Urology Practices on Oral Specialty Drug Use in Advanced Prostate CancerKassem S Faraj, Mary Oerline, Samuel R Kaufman, et al.
Cancer|November 6, 2024
Commercial prices and their influence on urology practices: Prostate cancer care among men with MedicareArnav Srivastava, Xiu Liu, Avinash Maganty, et al.
Pageof 2